Bio-Rad Laboratories, Inc. (BIO)
296.11
-1.17
(-0.39%)
USD |
NYSE |
Jul 10, 16:00
294.72
-1.39
(-0.47%)
Pre-Market: 08:28
Bio-Rad Laboratories Price to Book Value : 1.160 for July 10, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| July 10, 2026 | 1.160 |
| July 09, 2026 | 1.164 |
| July 08, 2026 | 1.112 |
| July 07, 2026 | 1.145 |
| July 06, 2026 | 1.156 |
| July 02, 2026 | 1.162 |
| July 01, 2026 | 1.163 |
| June 30, 2026 | 1.150 |
| June 29, 2026 | 1.156 |
| June 26, 2026 | 1.178 |
| June 25, 2026 | 1.168 |
| June 24, 2026 | 1.097 |
| June 23, 2026 | 1.058 |
| June 22, 2026 | 1.101 |
| June 18, 2026 | 1.106 |
| June 17, 2026 | 1.115 |
| June 16, 2026 | 1.135 |
| June 15, 2026 | 1.133 |
| June 12, 2026 | 1.120 |
| June 11, 2026 | 1.145 |
| June 10, 2026 | 1.140 |
| June 09, 2026 | 1.164 |
| June 08, 2026 | 1.141 |
| June 05, 2026 | 1.152 |
| June 04, 2026 | 1.204 |
| Date | Value |
|---|---|
| June 03, 2026 | 1.194 |
| June 02, 2026 | 1.199 |
| June 01, 2026 | 1.196 |
| May 29, 2026 | 1.224 |
| May 28, 2026 | 1.246 |
| May 27, 2026 | 1.196 |
| May 26, 2026 | 1.163 |
| May 22, 2026 | 1.127 |
| May 21, 2026 | 1.123 |
| May 20, 2026 | 1.127 |
| May 19, 2026 | 1.100 |
| May 18, 2026 | 1.104 |
| May 15, 2026 | 0.9693 |
| May 14, 2026 | 0.9644 |
| May 13, 2026 | 0.9535 |
| May 12, 2026 | 0.9465 |
| May 11, 2026 | 0.9546 |
| May 08, 2026 | 0.9959 |
| May 07, 2026 | 1.008 |
| May 06, 2026 | 1.014 |
| May 05, 2026 | 1.007 |
| May 04, 2026 | 1.010 |
| May 01, 2026 | 1.005 |
| April 30, 2026 | 1.097 |
| April 29, 2026 | 1.077 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Thermo Fisher Scientific, Inc. | 3.771 |
| Agilent Technologies, Inc. | 5.321 |
| Illumina, Inc. | 10.80 |
| Danaher Corp. | 2.660 |
| Bruker Corp. | 3.733 |
Price to Book Value Related Metrics
| PE Ratio | 48.74 |
| PS Ratio | 3.090 |
| Price to Free Cash Flow | 22.41 |
| Price | 296.11 |
| Earnings Yield | 2.05% |
| Market Cap | 7.944B |
| Operating PE Ratio | 33.09 |
| Normalized PE Ratio | 38.67 |